Protalix is a publicly traded biotechnology company
(NYSE Amex: PLX),
that is producing recombinant therapeutic proteins through the ProCellEx™ plant cell system.
HOME PAGE
ABOUT US
Corporate Profile
Market Needs
Protalix Advantage
Management Team
Scientific Advisory Board
Press Room
Careers
TECHNOLOGY
ProCellEx Overview
Platform Technology
Protein Production
PRODUCT DEVELOPMENT
taliglucerase alfa
Pipeline Products
PARTNERSHIPS
INVESTORS
Corporate Strategy
Board of Directors
Management Team
Stock Information
Corporate Governance
Filings
Press Releases
FAQs
EVENT CALENDER
CONTACT US
Patients
Investor Relations
EVENT CALENDER
EVENT CALENDER
Date
Event
Conference Location
February 16 - 18, 2011
the 7th Annual WORLD Symposium
Las Vegas, Nevada
March 1st – 3rd, 2011
Citi’s 2011 Global Health Care Conference
the Hilton New York Hotel in New York City, NY
© 2007 Protalix Biotherapeutics. All Rights Reserved.